July 22, 2025

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 41.45% Potential Upside with Strong Buy Ratings

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, is capturing investor attention with its strong growth trajectory and promising upside potential...

GRAIL, Inc. (GRAL) Stock Analysis: Exploring a 17.90% Potential Upside in the Healthcare Sector

GRAIL, Inc. (NASDAQ: GRAL) is making waves in the healthcare sector with its innovative approach to cancer detection and diagnostics. Headquartered in Menlo Park, California, this..

Twist Bioscience Corporation (TWST) Stock Analysis: A 39% Potential Upside in the Synthetic DNA Market

Twist Bioscience Corporation (NASDAQ: TWST) stands at the forefront of the synthetic DNA industry, crafting a niche in the rapidly evolving healthcare sector. With its headquarters..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: 16% Upside Potential Amid Strong Revenue Growth

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has been making waves in the biotechnology sector, particularly attracting attention with its potential upside of 16.01%. As a Canadian biopharmaceutical..

89bio, Inc. (ETNB): Analyst Consensus Points to a 191% Upside Potential

For investors with a focus on the biotechnology sector, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing proposition. With a market capitalization of $1.48 billion, this San..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Biotech Bet with 79% Potential Upside

For investors with an eye on the biotechnology sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents a compelling opportunity. With a market capitalization of $1.75 billion, the..

Liquidia Corporation (LQDA)

⚠️ No article content returned.

..

Enovis Corporation (ENOV) Stock Analysis: Exploring a Potential 114.83% Upside

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, specifically in the realm of medical devices, is capturing investor attention with its substantial potential..

Bausch Health Companies Inc. (BHC): Investor Outlook and 12% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC) presents an intriguing opportunity for investors eyeing the healthcare sector. With a market capitalization of $2.34 billion, this Canadian pharmaceutical..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Investor Outlook with 17.74% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a key player in the Healthcare sector, operates within the Medical Care Facilities industry. With a market capitalization nearing $929..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Exploring a 46.96% Upside Potential in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE), a pioneering player in the healthcare sector, is attracting investor attention with its innovative bioelectric medicine solutions. Specializing in the development..

Innoviva, Inc. (INVA) Stock Analysis: Uncovering a Potential 182% Upside in the Biotech Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is currently capturing the attention of investors with a remarkable potential upside of 182%. As..

Phreesia, Inc. (PHR) Stock Analysis: A 19% Potential Upside in Healthcare SaaS

Phreesia, Inc. (PHR), a prominent player in the healthcare information services sector, has been making waves with its robust growth metrics and promising analyst projections. Specializing..

Mesoblast Limited (MESO) Stock Analysis: Unveiling an 84% Potential Upside for Investors

Mesoblast Limited (NASDAQ: MESO), a pioneering biotech company in the healthcare sector, is capturing investor attention with its promising regenerative medicine platform. Headquartered in Melbourne, Australia,..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 31% Potential Upside in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out in the biotechnology industry with its commitment to developing innovative treatments for rare disorders. Headquartered in Warren, New Jersey,..

Artivion, Inc. (AORT) Stock Analysis: A Strong Buy Rating with a 6.77% Upside Potential

Artivion, Inc. (NASDAQ: AORT), a key player in the healthcare sector, particularly within the medical devices industry, is capturing investor attention with a notable market cap..

Kymera Therapeutics (KYMR) Stock Analysis: Impressive Revenue Growth and Strong Buy Ratings Signal Potential Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biotechnology firm at the cutting edge of therapeutic development, is captivating the attention of investors with its promising portfolio and..

Apellis Pharmaceuticals (APLS) Stock Analysis: A Biotech Powerhouse with 83% Upside Potential

For investors with an eye on the biotechnology sector, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents a compelling opportunity. With a market capitalization of $2.42 billion, this..

Neogen Corporation (NEOG) Stock Analysis: Unveiling a 56.9% Potential Upside for Investors

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, offers a compelling investment opportunity with a notable potential upside..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Unpacking the 320.97% Potential Upside and Strong Analyst Confidence

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its ambitious pipeline targeting chronic diseases. With a market..

Search

Funds

July 22, 2025

Search

Funds

July 22, 2025

FTSE 100

Funds